Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
BEDFORD, Mass., April 11, 2017 -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 10, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2017. To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 5263799.
The conference call will be hosted by Mark Augusti, President and Chief Executive Officer, and Paul Weiner, Chief Financial Officer. The company will issue a news release announcing its first quarter 2017 financial results on Wednesday, May 10, 2017, prior to the conference call.
A live webcast of the conference call will also be available in the investor relations section of the company’s website at ir.conformis.com. The online archive of the webcast will be available on the company’s website for 30 days.
About ConforMIS, Inc.
ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 450 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com/.
Contact Investor Contact: Oksana Bradley [email protected] (781) 374-5598
